📋 Tender Overview
Contract awarded for Framework agreement for oncological medicines 16 batches lot-0003, title: cabazitaxel conc. + sol. / sol. perf. 60 mg (1.5ml concentrate + 4.5ml solvent), description: cabazitaxel conc. + sol. / sol. perf. 60 mg (1.5ml concentrate + 4.5ml solvent) minimum quantity framework agreement 10 maximum quantity framework agreement 50 lot-0004, title: docetaxel conc. for sol. / perf. 20mg/ml - 7ml, description: docetaxel conc. for sol. / perf. 20mg/ml - 7ml minimum quantity framework agreement 10 maximum quantity framework agreement 300 lot-0009, title: epirubicin solution inj / perf. 2mg/ml - 25 ml, description: epirubicin solution inj / perf. 2mg/ml - 25 ml minimum quantity framework agreement 10 maximum quantity framework agreement 200 lot-0015, title: etoposide conc. for sol. / perf. 20 mg/ml-10 ml, description: etoposide conc. for sol. / perf. 20 mg/ml-10 ml minimum quantity framework agreement 10 maximum quantity framework agreement 200 lot-0016, title: pemetrexed powder for sol. perf. 25mg/ml-20 ml 500 mg, description: pemetrexed powder for sol. perf. 25mg/ml-20 ml 500 mg minimum quantity framework agreement 10 maximum quantity framework agreement 200 estimated value excluding vat: 36218.00 ron.Framework agreement for oncological medicines 16 batches